Hostname: page-component-84b7d79bbc-g78kv Total loading time: 0 Render date: 2024-07-29T10:14:04.315Z Has data issue: false hasContentIssue false
  • English
  • Français

181 Diaspirin Cross-linked Hemoglobin (DCLHb™): Phase I Clinical Safety Assessment in Normal Healthy Volunteers

Published online by Cambridge University Press:  28 June 2012

R Przybelski ,
J Kisicki ,
E Daily ,
M Bounds  and
C Mattia-Goldberg
R Przybelski
Affiliation:
Baxter Healthcare Corporation, Round Lake, IL, USA, Harris Laboratories, Lincoln, NE, USA
J Kisicki
Affiliation:
Baxter Healthcare Corporation, Round Lake, IL, USA, Harris Laboratories, Lincoln, NE, USA
E Daily
Affiliation:
Baxter Healthcare Corporation, Round Lake, IL, USA, Harris Laboratories, Lincoln, NE, USA
M Bounds
Affiliation:
Baxter Healthcare Corporation, Round Lake, IL, USA, Harris Laboratories, Lincoln, NE, USA
C Mattia-Goldberg
Affiliation:
Baxter Healthcare Corporation, Round Lake, IL, USA, Harris Laboratories, Lincoln, NE, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Emergency Medicine
Information
Prehospital and Disaster Medicine , Volume 8 , supplement S3: Abstracts of Scientific Papers 8th World Congress on Emergency and Disaster Medicine, Stockholm, Sweden 20–23 June 1993 , September 1993 , pp. S115 - S116
Copyright
Copyright © World Association for Disaster and Emergency Medicine 1993